CN101948809B - Inactivated vaccine for preventing duck viral hepatitis and preparation method thereof - Google Patents
Inactivated vaccine for preventing duck viral hepatitis and preparation method thereof Download PDFInfo
- Publication number
- CN101948809B CN101948809B CN2010102473069A CN201010247306A CN101948809B CN 101948809 B CN101948809 B CN 101948809B CN 2010102473069 A CN2010102473069 A CN 2010102473069A CN 201010247306 A CN201010247306 A CN 201010247306A CN 101948809 B CN101948809 B CN 101948809B
- Authority
- CN
- China
- Prior art keywords
- cell
- dhav
- vaccine
- duck
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000272525 Anas platyrhynchos Species 0.000 title claims abstract description 94
- 206010019799 Hepatitis viral Diseases 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 229940031551 inactivated vaccine Drugs 0.000 title abstract description 29
- 201000001862 viral hepatitis Diseases 0.000 title abstract description 19
- 241000700605 Viruses Species 0.000 claims abstract description 23
- 241001651352 Avihepatovirus A Species 0.000 claims abstract description 4
- 210000004027 cell Anatomy 0.000 claims description 92
- 239000007788 liquid Substances 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 28
- 230000003612 virological effect Effects 0.000 claims description 26
- 239000006228 supernatant Substances 0.000 claims description 24
- 238000011081 inoculation Methods 0.000 claims description 19
- 230000009849 deactivation Effects 0.000 claims description 18
- 231100000614 poison Toxicity 0.000 claims description 18
- 239000002574 poison Substances 0.000 claims description 18
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 13
- 239000012930 cell culture fluid Substances 0.000 claims description 11
- 229960002520 hepatitis vaccine Drugs 0.000 claims description 10
- 239000003921 oil Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 239000006285 cell suspension Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000010257 thawing Methods 0.000 claims description 6
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 6
- 238000004945 emulsification Methods 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 230000008021 deposition Effects 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 4
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 210000004691 chief cell of stomach Anatomy 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 2
- 229940030156 cell vaccine Drugs 0.000 abstract description 14
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 230000005847 immunogenicity Effects 0.000 abstract description 3
- 208000006454 hepatitis Diseases 0.000 abstract description 2
- 231100000283 hepatitis Toxicity 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 description 66
- 238000010254 subcutaneous injection Methods 0.000 description 43
- 239000007929 subcutaneous injection Substances 0.000 description 43
- 238000012360 testing method Methods 0.000 description 13
- 230000036039 immunity Effects 0.000 description 10
- 241000287828 Gallus gallus Species 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 230000003053 immunization Effects 0.000 description 7
- 241000272522 Anas Species 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 238000007689 inspection Methods 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 206010067484 Adverse reaction Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000006838 adverse reaction Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 230000001524 infective effect Effects 0.000 description 4
- 230000007170 pathology Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 230000009885 systemic effect Effects 0.000 description 4
- 231100000167 toxic agent Toxicity 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- 241000204031 Mycoplasma Species 0.000 description 3
- 241000228143 Penicillium Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 238000005138 cryopreservation Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000009781 safety test method Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 238000004114 suspension culture Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000041 toxicology testing Toxicity 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 241001557655 Duck hepatitis A virus 2 Species 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 238000004500 asepsis Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 210000003292 kidney cell Anatomy 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- 230000001018 virulence Effects 0.000 description 2
- 239000005723 virus inoculator Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- UPLPHRJJTCUQAY-WIRWPRASSA-N 2,3-thioepoxy madol Chemical compound C([C@@H]1CC2)[C@@H]3S[C@@H]3C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C)(O)[C@@]2(C)CC1 UPLPHRJJTCUQAY-WIRWPRASSA-N 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 241001651353 Avihepatovirus Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 241001557661 Duck hepatitis A virus 3 Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010076039 Polyproteins Proteins 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000723848 Tobamovirus Species 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000002976 pectoralis muscle Anatomy 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
The viral dilution degree | The hole count that CPE occurs |
10 3 | 16/16 |
10 4 | 16/16 |
10 5 | 16/16 |
10 6 | 13/16 |
10 7 | 7/16 |
10 8 | 1/16 |
10 9 | 0/16 |
10 10 |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102473069A CN101948809B (en) | 2010-08-06 | 2010-08-06 | Inactivated vaccine for preventing duck viral hepatitis and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102473069A CN101948809B (en) | 2010-08-06 | 2010-08-06 | Inactivated vaccine for preventing duck viral hepatitis and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101948809A CN101948809A (en) | 2011-01-19 |
CN101948809B true CN101948809B (en) | 2012-08-15 |
Family
ID=43452441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102473069A Active CN101948809B (en) | 2010-08-06 | 2010-08-06 | Inactivated vaccine for preventing duck viral hepatitis and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101948809B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102228481B (en) * | 2011-06-28 | 2013-03-13 | 重庆市畜牧科学院 | Propolis injection for preventing type I duck virus hepatitis and preparation method thereof |
CN102580116A (en) * | 2011-12-21 | 2012-07-18 | 中国农业科学院上海兽医研究所 | Duck virus hepatitis suicide DNA vaccine, as well as constructing method and application thereof |
CN103013931B (en) * | 2012-12-21 | 2014-12-03 | 哈药集团生物疫苗有限公司 | DHAV (duck hepatitis A virus) JS strain and application of DHAV JS strain in duck virus hepatitis prevention and cure |
CN104530230B (en) * | 2014-12-13 | 2018-01-30 | 惠安易成机电设备工程有限公司 | A kind of duck hepatitis A virus VP1 GFPs and its application |
CN104531625B (en) * | 2014-12-26 | 2017-07-28 | 中国科学院微生物研究所 | A kind of inactivated vaccine of duck virus hepatitis and preparation method and application |
CN106177938A (en) * | 2016-08-30 | 2016-12-07 | 哈药集团生物疫苗有限公司 | Duck viral hepatitis bivalent inactivated vaccine and preparation method thereof |
CN106591493B (en) * | 2016-12-30 | 2020-09-29 | 博奥生物集团有限公司 | Primer combination for identifying duck hepatitis virus and application thereof |
CN109295008A (en) * | 2018-10-09 | 2019-02-01 | 华农(肇庆)生物产业技术研究院有限公司 | A kind of full suspension culture method of duck hepatitis virus |
CN112266984B (en) * | 2020-11-13 | 2022-05-24 | 福建省农业科学院畜牧兽医研究所 | Differential diagnosis method for discriminating DHAV-1 wild virus and vaccine attenuated virus |
CN112375747B (en) * | 2020-11-18 | 2022-11-01 | 辽宁益康生物股份有限公司 | Duck viral hepatitis virus vaccine strain, vaccine and vaccine preparation method |
-
2010
- 2010-08-06 CN CN2010102473069A patent/CN101948809B/en active Active
Non-Patent Citations (1)
Title |
---|
李婵等.一株I型鸭肝炎病毒的分离与鉴定.《广西畜牧兽医》.2009,第25卷(第1期),18-19. * |
Also Published As
Publication number | Publication date |
---|---|
CN101948809A (en) | 2011-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102174476B (en) | Inactivated vaccine for preventing duck virus hepatitis and preparation method thereof | |
CN101948809B (en) | Inactivated vaccine for preventing duck viral hepatitis and preparation method thereof | |
CN104922663B (en) | A kind of newcastle disease and H9 subtype avian influenza bigeminy vaccines | |
CN102492661B (en) | Preparation method and application of immunization preparation for controlling novel duck reovirus | |
CN101612397B (en) | Duck virus hepatitis inactivated vaccine and preparation method thereof | |
CN104946600B (en) | A kind of H9 subtype avian influenza virus strain | |
CN104587460B (en) | Mink viral enteritis, canine distemper bigeminal live vaccine and its preparation method and application | |
CN105031638A (en) | Trivalent inactivated vaccine against Newcastle disease, avian influenza and infectious bursal disease | |
CN102068695B (en) | Method for producing quadruple inactivated vaccine for newcastle disease, infectious bronchitis, avian influenza (H9 subtype) and infectious bursal disease | |
CN103143008B (en) | Duck tembusu virus living vaccine and preparation method thereof | |
CN103013931B (en) | DHAV (duck hepatitis A virus) JS strain and application of DHAV JS strain in duck virus hepatitis prevention and cure | |
CN103833848A (en) | Egg yolk antibody for preventing and curing muscovy duck parvovirus diseases | |
CN105274064B (en) | A kind of duck tembusu virus attenuated vaccine strain and its application | |
CN102908618B (en) | Preparation method of divalent inactivated vaccines for duck virus hepatitis | |
CN104087559B (en) | A kind of infectious bursa of Fabricius virus, inactivated vaccine and preparation method thereof | |
CN103143009A (en) | Method for producing duck tembusu virus inactivated vaccines in large scale | |
CN103525772A (en) | Strain of duck viral hepatitis virus and application thereof | |
CN106854647A (en) | Duck virus hepatitis divalence yolk antibody and its preparation method and application | |
CN104130981A (en) | Application of avian infectious bronchitis virus vaccine strain in preparation of inactivated vaccine | |
CN104069489B (en) | Newcastle disease and infectious bursa of Fabricius bivalent inactivated vaccine and preparation method thereof | |
CN102166355B (en) | Quadruple inactivated vaccine for preventing chicken diseases | |
CN101130075A (en) | Tervalence inactivated vaccine for type O, A, Asia-1 hoof-and-mouth disease | |
CN104195114A (en) | Avian pneumovirus and application thereof | |
CN103122336B (en) | Goose parvovirus H-strain and application thereof in preventing and treating gosling plague | |
CN109762062A (en) | A kind of preparation method of goose goat Yolk antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING DABEINONG TECHNOLOGY GROUP CO., LTD. Free format text: FORMER OWNER: MICROBIOLOGY INST., CHINESE ACADEMY OF SCIENCES Effective date: 20120427 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Wenjun Inventor after: Wang Guihua Inventor after: Li Jing Inventor after: Zhao Yarong Inventor after: Mou Wei Inventor before: Liu Wenjun Inventor before: Zhou Yuancheng Inventor before: Sun Lei Inventor before: Li Jing |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100101 CHAOYANG, BEIJING TO: 100097 HAIDIAN, BEIJING Free format text: CORRECT: INVENTOR; FROM: LIU WENJUN ZHOU YUANCHENG SUN LEI LI JING TO: LIU WENJUN WANG GUIHUA LI JING ZHAO YARONG MOU WEI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120427 Address after: 100097, No. 9 Shuguang Road, Haidian District, Beijing Applicant after: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. Address before: 100101 Institute of Microbiology, Chinese Academy of Sciences, No. 1, West Beichen Road, Chaoyang District, Beijing, A315, Applicant before: Institute of Microbiology, Chinese Academy of Sciences |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200108 Address after: 363502, Fujian, Zhangzhou province Zhaoan County gold industrial concentration zone Co-patentee after: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. Patentee after: FUJIAN DABEINONG FISHERIES SCIENCE & TECHNOLOGY Co.,Ltd. Address before: 100097, No. 9 Shuguang Road, Haidian District, Beijing Patentee before: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 363502 Jindu Industrial Concentration Zone, Zhaoan County, Zhangzhou City, Fujian Province Patentee after: Fujian shenshuang aquatic products Technology Group Co.,Ltd. Patentee after: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. Address before: 363502 Jindu Industrial Concentration Zone, Zhaoan County, Zhangzhou City, Fujian Province Patentee before: FUJIAN DABEINONG FISHERIES SCIENCE & TECHNOLOGY Co.,Ltd. Patentee before: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210202 Address after: 211102, 999 Ting Dong Road, Jiangning economic and Technological Development Zone, Nanjing, Jiangsu Patentee after: Zhaofenghua Biotechnology (Nanjing) Co.,Ltd. Patentee after: Beijing Biomedical Technology Center of zhaofenghua Biotechnology (Nanjing) Co.,Ltd. Patentee after: BEIJING KEMUFENG BIOLOGICAL PHARMACEUTICAL Co.,Ltd. Address before: 363502 Jindu Industrial Concentration Zone, Zhaoan County, Zhangzhou City, Fujian Province Patentee before: Fujian shenshuang aquatic products Technology Group Co.,Ltd. Patentee before: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. |